Emmaus Life Sciences, Inc.

EMMA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 May 25, 2021 FORM 4 SUBMISSION
4 May 20, 2021 FORM 4 SUBMISSION
8-K May 19, 2021 CURRENT REPORT
NT 10-Q May 17, 2021 NOTIFICATION OF LATE FILING
4 May 14, 2021 FORM 4 SUBMISSION
4 May 12, 2021 FORM 4 SUBMISSION
4 May 10, 2021 FORM 4 SUBMISSION
4 May 7, 2021 FORM 4 SUBMISSION
10-K May 4, 2021 10-K
NT 10-K Mar 31, 2021 NOTIFICATION OF LATE FILING
8-K Feb 22, 2021 CURRENT REPORT
D Feb 16, 2021
8-K Feb 16, 2021 CURRENT REPORT
10-K Jan 25, 2021 10-K
8-K Nov 13, 2020 CURRENT REPORT
8-K Nov 5, 2020 CURRENT REPORT
8-K Oct 29, 2020 CURRENT REPORT
8-K Oct 20, 2020 CURRENT REPORT
4 Oct 16, 2020 FORM 4 SUBMISSION
4 Oct 15, 2020 FORM 4 SUBMISSION
4 Oct 13, 2020 FORM 4 SUBMISSION
D/A Oct 9, 2020
4 Oct 9, 2020 FORM 4 SUBMISSION
8-K/A Oct 8, 2020 CURRENT REPORT
D/A Oct 7, 2020
← Newer Page 9 of 50 · 1238 filings Older →